NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies

NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies

The mechanism of action of recombinant IgG2/4 antibodies involves blocking of their target without the induction of effector functions. Examples are eculizumab (Soliris®), which is used clinically to block complement factor C5, as well as anti-human CD14 (r18D11) and anti-porcine CD14 (rMIL2) produc...

Full description

Saved in:
Bibliographic Details
Main Authors: Corinna Lau (Author), Martin Berner McAdam (Author), Grethe Bergseth (Author), Algirdas Grevys (Author), Jack Ansgar Bruun (Author), Judith Krey Ludviksen (Author), Hilde Fure (Author), Terje Espevik (Author), Anders Moen (Author), Jan Terje Andersen (Author), Tom Eirik Mollnes (Author)
Format: Book
Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items